Danillo Vladimir Vojvodic

Prof. Danillo Vladimir Vojvodic

Military Medical Academy, Belgrade, Beograd, Serbia
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
MDMirjana Djukic
Mirjana Djukic
MFMara Fesatidou
Mara Fesatidou
IXIakovos Xenikakis
Iakovos Xenikakis
Athina GeronikakiAthina Geronikaki
Athina Geronikaki
VAViolina T. Angelova
Violina T. Angelova
Luciano SasoLuciano Saso
Luciano Saso

1 May 2010 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
APA.B. Petković
A.B. Petković
SMS.M. Matić
S.M. Matić
NSN.V. Stamatović
N.V. Stamatović
DVDanillo Vladimir Vojvodic
Danillo Vladimir Vojvodic
TTT.M. Todorović
T.M. Todorović
RKR.J. Kozomara
R.J. Kozomara

16 June 2015 in Scientific Reports
Verified
Journal Article
Open access
MSMaja Surbatovic
Maja Surbatovic
NPNada Popovic
Nada Popovic
DVDanillo Vladimir Vojvodic
Danillo Vladimir Vojvodic
IMIvan Milosevic
Ivan Milosevic
GAGordana Acimovic
Gordana Acimovic
SRSonja Radakovic
Sonja Radakovic
Sepsis is a principal cause of death in critical care units worldwide and consumes considerable healthcare resources. The aim of our study was to determine whether the early cytokine profile can discriminate between Gram-positive and Gram-negative bacteraemia (GPB and GNB, respectively) and to assess the prognostic value regarding outcome in critically ill patients with severe abdominal sepsis. The outcome measure was hospital mortality. Blood samples were obtained from 165 adult patients with confirmed severe abdominal sepsis. Levels of the proinflammatory mediators TNF-α, IL-8, IL-12 and IFN-γ and the anti-inflammatory mediators IL-1ra, IL-4, IL-10 and TGF-β1 were determined and correlated with the nature of the bacteria isolated from the blood culture and outcome. The cytokine profile in our study indicated that the TNF-α levels were 2-fold, IL-8 were 3.3-fold, IFN-γ were 13-fold, IL-1ra were 1.05-fold, IL-4 were 1.4-fold and IL-10 were 1.83-fold higher in the GNB group compared with the GPB group. The TNF-α levels were 4.7-fold, IL-8 were 4.6-fold, IL-1ra were 1.5-fold and IL-10 were 3.3-fold higher in the non-survivors compared with the survivors.

1 November 2014 in Journal of Periodontology
Verified
Journal Article
Closed access
Mia RAKICMia RAKIC
Mia RAKIC
XSXavier Struillou
Xavier Struillou
APAleksandra Petkovic‐Curcin
Aleksandra Petkovic‐Curcin
SMSmiljana Matic
Smiljana Matic
Luigi CanulloLuigi Canullo
Luigi Canullo
DVDanillo Vladimir Vojvodic
Danillo Vladimir Vojvodic
Background: The aims of this study are to estimate the profile of bone loss biomarkers in peri‐implant tissues and to identify potential prognostic biomarkers of peri‐implantitis.Methods: Peri‐implant crevicular fluid samples collected from 164 participants (52 patients with peri‐implantitis, 54 with mucositis, and 58 with healthy peri‐implant tissues) were analyzed using enzyme‐linked immunosorbent assays to evaluate concentrations of the receptor activator of nuclear factor‐κB (RANK), soluble RANK ligand (sRANKL), osteoprotegerin (OPG), cathepsin‐K, and sclerostin.Results: Concentrations of RANK, sRANKL, OPG, and sclerostin were significantly increased in patients with peri‐implantitis compared with patients with healthy peri‐implant tissues. Comparisons between peri‐implantitis and mucositis demonstrated significantly higher values of sclerostin in peri‐implantitis samples. Comparisons between mucositis and healthy peri‐implant tissues showed significantly increased levels of RANK and cathepsin‐K in mucositis.Conclusion: These results are suggestive of a role of sRANKL, OPG, and sclerostin as prognostic biomarkers in peri‐implantitis.

18 June 2012 in Clinical Oral Implants Research
Verified
Journal Article
Closed access
PDF file
Mia RAKICMia RAKIC
Mia RAKIC
VLVojislav Lekovic
Vojislav Lekovic
NNNatasa Nikolic‐Jakoba
Natasa Nikolic‐Jakoba
DVDanillo Vladimir Vojvodic
Danillo Vladimir Vojvodic
APAleksandra Petkovic‐Curcin
Aleksandra Petkovic‐Curcin
MSMariano Sanz
Mariano Sanz

Verified
Journal Article
Open access
PDF file
GVGordana Velikic
Gordana Velikic
DMDusan Maric
Dusan Maric
DMDusica Lazar Maric
Dusica Lazar Maric
GSGordana Supic
Gordana Supic
MPMiljan Puletic
Miljan Puletic
DVDanillo Vladimir Vojvodic
Danillo Vladimir Vojvodic
Regenerative medicine harnesses the body’s innate capacity for self-repair to restore malfunctioning tissues and organs. Stem cell therapies represent a key regenerative strategy, but to effectively harness their potential necessitates a nuanced understanding of the stem cell niche. This specialized microenvironment regulates critical stem cell behaviors including quiescence, activation, differentiation, and homing. Emerging research reveals that dysfunction within endogenous neural stem cell niches contributes to neurodegenerative pathologies and impedes regeneration. Strategies such as modifying signaling pathways, or epigenetic interventions to restore niche homeostasis and signaling, hold promise for revitalizing neurogenesis and neural repair in diseases like Alzheimer’s and Parkinson’s. Comparative studies of highly regenerative species provide evolutionary clues into niche-mediated renewal mechanisms. Leveraging endogenous bioelectric cues and crosstalk between gut, brain, and vascular niches further illuminates promising therapeutic opportunities. Emerging techniques like single-cell transcriptomics, organoids, microfluidics, artificial intelligence, in silico modeling, and transdifferentiation will continue to unravel niche complexity. By providing a comprehensive synthesis integrating diverse views on niche components, developmental transitions, and dynamics, this review unveils new layers of complexity integral to niche behavior and function, which unveil novel prospects to modulate niche function and provide revolutionary treatments for neurodegenerative diseases.